Health Canada approves Moderna flu and flu-COVID vaccines for seniors

Health Canada approves Moderna flu and flu-COVID vaccines for seniors

Health
Sign in to pin this event

Health Canada approved Moderna's mFLUSIVA influenza vaccine and its mCOFLU combined flu-COVID-19 shot for adults aged 50 and older on 5 November, marking the first time a country has authorized both products. According to CBC, the approval positions Canada as the pioneer in granting regulatory clearance for the two vaccines, and the news was reported on 6 November. The approval follows Moderna's submission of data on the safety and efficacy of the mRNA-based flu vaccine and the flu-COVID combination, which regulators reviewed before granting clearance.

Actors

Health Canada Moderna The Canadian Press National Advisory Committee on Immunization Pfizer

Locations

Canada United States Europe

Fact Check

How these metrics work
Verdict: Partial Confidence: 50% Claims: 2
At a glance

There is not enough evidence to confirm that Health Canada authorized Moderna's combined flu-COVID-19 shot for adults aged 50 and older on November 6, 2026. There is also insufficient evidence to verify that Health Canada authorized Moderna's mRNA influenza vaccine for adults aged 50 and older on the same date. It is partially confirmed that Canada is the first country to approve both Moderna's mRNA influenza vaccine and its combined flu-COVID-19 shot for adults 50 and older. The claim that Moderna stated their authorized vaccines will not be available in pharmacies before the upcoming respiratory virus season is refuted.

Sign in or subscribe to unlock the full breakdown: claims, sources, and validations.

Sign up Sign in

This section contains an automated verification of claims against external sources and may contain inaccuracies.

Articles

November 06, 2026
6 total
Health Canada authorizes Moderna's flu and combined flu-COVID vaccines for adults 50+
Health Canada authorizes Moderna's flu and combined flu-COVID vaccines for adults 50+

Global News • 06 Nov 18:55

Health Canada approved Moderna's mFLUSIVA flu vaccine and mCOFLU combined flu-COVID shot for adults aged 50 and older, marking the first country to authorize both products.

Credibility 88% Manip. 8% Center
Health Canada approves Moderna's mRNA flu vaccine and flu-COVID combo for seniors
Health Canada approves Moderna's mRNA flu vaccine and flu-COVID combo for seniors

CBC • 06 Nov 16:39

Moderna's mRNA influenza vaccine and its combined flu-COVID-19 shot have been authorized for adults 50 and older, making Canada the first country to approve both products.

Credibility 92% Manip. 8% Center
Health Canada approves new Moderna mRNA-flu vaccine
Health Canada approves new Moderna mRNA-flu vaccine

CHCH • 06 Nov 12:42

Health Canada has authorized a combined mRNA COVID-19 and influenza vaccine from Moderna for use in Canada.

Credibility 32% Manip. 8% Center
Health Canada authorizes Moderna's mRNA flu and flu-COVID-19 combo vaccines
Health Canada authorizes Moderna's mRNA flu and flu-COVID-19 combo vaccines

CityNews Vancouver • 06 Nov 00:36

Moderna's mRNA influenza vaccine and its combined flu-COVID-19 shot have received approval for adults 50 and older, though the company says distribution will miss the upcoming respiratory season.

Credibility 88% Manip. 5% Center
Health Canada authorises Moderna's flu and flu-COVID-19 mRNA vaccines for seniors
Health Canada authorises Moderna's flu and flu-COVID-19 mRNA vaccines for seniors

CKPG Today • 06 Nov 00:23

Health Canada has approved Moderna's standalone influenza vaccine, mFLUSIVA, and its combined flu-COVID-19 vaccine, mCOFLU, for adults aged 50 and older, making Canada the first country to authorize both products.

Credibility 88% Manip. 8% Center
Health Canada authorizes Moderna's mRNA flu vaccine and flu-COVID combo for seniors
Health Canada authorizes Moderna's mRNA flu vaccine and flu-COVID combo for seniors

CityNews Toronto • 06 Nov 00:19

Moderna's mRNA influenza vaccine and its combined flu-COVID-19 shot have been approved by Health Canada for adults aged 50 and older, though the company says they will not reach pharmacies before the upcoming respiratory virus season.

Credibility 88% Manip. 5% Center

Related events